Literature DB >> 2857900

Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome.

J Egger, C M Carter, P J Graham, D Gumley, J F Soothill.   

Abstract

76 selected overactive children were treated with an oligoantigenic diet, 62 improved, and a normal range of behaviour was achieved in 21 of these. Other symptoms, such as headaches, abdominal pain, and fits, also often improved. 28 of the children who improved completed a double-blind, crossover, placebo-controlled trial in which foods thought to provoke symptoms were reintroduced. Symptoms returned or were exacerbated much more often when patients were on active material than on placebo. 48 foods were incriminated. Artificial colorants and preservatives were the commonest provoking substances, but no child was sensitive to these alone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857900     DOI: 10.1016/s0140-6736(85)91206-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  48 in total

1.  Attention deficit disorder and food intolerance.

Authors:  J Dolovich
Journal:  CMAJ       Date:  1992-12-15       Impact factor: 8.262

2.  Chemical intolerance in primary care settings: prevalence, comorbidity, and outcomes.

Authors:  David A Katerndahl; Iris R Bell; Raymond F Palmer; Claudia S Miller
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

3.  Does oligoantigenic diet influence hyperactive/conduct-disordered children--a controlled trial.

Authors:  M H Schmidt; P Möcks; B Lay; H G Eisert; R Fojkar; D Fritz-Sigmund; A Marcus; B Musaeus
Journal:  Eur Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 4.785

4.  Coincidence of attention deficit disorder and atopic disorders in children: empirical findings and hypothetical background.

Authors:  N Roth; J Beyreiss; K Schlenzka; H Beyer
Journal:  J Abnorm Child Psychol       Date:  1991-02

5.  Effect of artificial food colours on childhood behaviour.

Authors:  I Pollock; J O Warner
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

6.  The use of alternative therapies in treating children with attention deficit hyperactivity disorder.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-12       Impact factor: 2.253

7.  Lay epidemiology and the rationality of responses to health education.

Authors:  S Frankel; C Davison; G D Smith
Journal:  Br J Gen Pract       Date:  1991-10       Impact factor: 5.386

8.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

9.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication.

Authors:  Robert D Oades; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz; Aye-Mu Myint
Journal:  Behav Brain Funct       Date:  2010-05-28       Impact factor: 3.759

10.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention.

Authors:  Robert D Oades; Aye-Mu Myint; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz
Journal:  Behav Brain Funct       Date:  2010-06-09       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.